Previous close | 2.9400 |
Open | 2.9700 |
Bid | 2.9800 x N/A |
Ask | 3.0800 x N/A |
Day's range | 2.9700 - 2.9700 |
52-week range | 2.6100 - 4.0400 |
Volume | |
Avg. volume | 264 |
Market cap | 142.654M |
Beta (5Y monthly) | -0.31 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4400 |
Earnings date | 11 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.30 |
Heidelberg Pharma ( ETR:HPHA ) First Quarter 2024 Results Key Financial Results Revenue: €1.86m (down 10% from 1Q...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the first patient has been enrolled in the Austere environments Consortium for Enhanced Sepsis Outcomes' (ACESO) U.S. government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment. RHB-107 (upamostat) is the first drug being tested in this platform study. Funded through non-dilutive external sources, including the U.S. Department of D
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term...